Hysteroscopy in the Clinic: Application of Clinical Pathway

Author(s): María Dolores Lara Domínguez*, Carlota García-Salmones González, Elena Mantrana Bermejo, Virginia Caballero Fernández, María Rosa Oña López

Journal Name: Current Women`s Health Reviews

Volume 16 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: A retrospective study that analysed data for three consecutive years from the Hysteroscopy Clinic at the Department of Obstetrics and Gynecology, Valme University Hospital.

Objective: To analyse the data of lesions removed in the hysteroscopy clinic in comparison with those scheduled for the operating room to show that hysteroscopy could be a more effective procedure.

Methods: Patients undergoing operative hysteroscopy for various indications were included. The 5 mm Bettocchi hysteroscopes and the 5.8 mm Palex Mini-Resectoscope were used.

Results: A total of 1233 patients were seen in the hysteroscopy clinic between 2015 and 2017. In 2015, 344 hysteroscopies were performed, of which 57 (16.5%) were performed in the operating room. In 2016, 445 hysteroscopies were performed and 46 (10.3%) were scheduled in the operating room. During 2017, a total of 444 hysteroscopies were performed, of which only 6 (1.3%) were performed in the operating room (P < 0.001). Five large fibroids and one case of complex polyp were removed in the operating room in 2017. The mini-resector was used in 202 cases (45.4%). Paracervical local anaesthesia was given to 383 (86.2%) patients.

Conclusion: The data obtained in our study shows a significant reduction in the number of hysteroscopies scheduled for surgery in 2017 (1.3%) and, therefore, hysteroscopy has been shown to be a more effective procedure. This trend may be due to the introduction of the mini-resectoscope and the use of paracervical local anaesthesia.

Keywords: Clinical pathway, hysteroscopic surgery, office hysteroscopy, operative hysteroscopy, outpatient hysteroscopy, paracervical anaesthesia, submucosal myoma.

[1]
Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. Am J Obstet Gynecol 1996; 174(6): 1678-82.
[http://dx.doi.org/10.1016/S0002-9378(96)70196-5] [PMID: 8678126]
[2]
Lara-Domínguez MD, Arjona-Berral JE, Dios-Palomares R, Castelo-Branco C. Outpatient hysteroscopic polypectomy: bipolar energy system (Versapoint®) versus diode laser - randomized clinical trial. Gynecol Endocrinol 2016; 32(3): 196-200.
[http://dx.doi.org/10.3109/09513590.2015.1105209] [PMID: 26527251]
[3]
Diwakar L, Roberts TE, Cooper NAM, et al. OPT trial collaborative group. An economic evaluation of outpatient versus inpatient polyp treatment for abnormal uterine bleeding. BJOG 2016; 123(4): 625-31.
[http://dx.doi.org/10.1111/1471-0528.13434] [PMID: 26011792]
[4]
Moawad NS, Santamaria E, Johnson M, Shuster J. Cost- Effectiveness of Office Hysteroscopy for Abnormal Uterine Bleeding. JSLS 2014; 18(3) pii: e2014.00393.
[http://dx.doi.org/10.4293/JSLS.2014.00393]
[5]
Vilos GA. Intrauterine surgery using a new coaxial bipolar electrode in normal saline solution (Versapoint): a pilot study. Fertil Steril 1999; 72(4): 740-3.
[PMID: 10521122]
[6]
Farrugia M. MCGurgan P, MCMillan L, O’Donovan P. Recent advances in electrosurgery-Versapoint technology. Rev Gynaecol Pract 2001; 1: 12-7.
[http://dx.doi.org/10.1016/S1471-7697(01)80030-7]
[7]
Dealberti D, Riboni F, Prigione S, et al. New mini-resectoscope: analysis of preliminary quality results in outpatient hysteroscopic polypectomy. Arch Gynecol Obstet 2013; 288(2): 349-53.
[http://dx.doi.org/10.1007/s00404-013-2754-7] [PMID: 23417150]
[8]
Dealberti D, Riboni F, Cosma S, et al. Feasibility and acceptability of office-based polypectomy with a 16F mini-resectoscope: A multicenter clinical study. J Minim Invasive Gynecol 2016; 23(3): 418-24.
[http://dx.doi.org/10.1016/j.jmig.2015.12.016] [PMID: 26767826]
[9]
Di Spiezio Sardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update 2008; 14(2): 101-19.
[http://dx.doi.org/10.1093/humupd/dmm041] [PMID: 18063608]
[10]
Smith PP, Kolhe S, O’Connor S, Clark TJ. Vaginoscopy Against Standard Treatment: a randomised controlled trial. BJOG 2019; 126(7): 891-9.
[http://dx.doi.org/10.1111/1471-0528.15665] [PMID: 30801889]
[11]
Ma T, Readman E, Hicks L, et al. Is outpatient hysteroscopy the new gold standard? Results from an 11 year prospective observational study. Aust N Z J Obstet Gynaecol 2017; 57(1): 74-80.
[http://dx.doi.org/10.1111/ajo.12560] [PMID: 27861704]
[12]
Smits RM, Kuijsters NP, Braam L, Van Vliet H, Schoot BC. Therapeutic hysteroscopy in an outpatient office-based setting compared to conventional inpatient treatment: superior? a cohort study. Gynecol Surg 2016; 13(4): 339-44.
[http://dx.doi.org/10.1007/s10397-016-0974-0]
[13]
Capmas P, Pourcelot AG, Giral E, Fedida D, Fernandez H. Office hysteroscopy: A report of 2402 cases. J Gynecol Obstet Biol Reprod (Paris) 2016; 45(5): 445-50.
[http://dx.doi.org/10.1016/j.jgyn.2016.02.007] [PMID: 27055773]
[14]
Kopitović V, Budakov D, Pjević AT, et al. Results and experiences after 2000 performed hysteroscopies. Srp Arh Celok Lek 2012; 140(11-12): 728-31.
[http://dx.doi.org/10.2298/SARH1212728K] [PMID: 23350246]
[15]
Mairos J, Di Martino P. Office Hysteroscopy. An operative gold standard technique and an important contribution to Patient Safety. Gynecol Surg 2016; 13: 111-4.
[http://dx.doi.org/10.1007/s10397-015-0926-0] [PMID: 27226786]
[16]
Salazar CA, Isaacson KB. Office operative hysteroscopy: An update. J Minim Invasive Gynecol 2018; 25(2): 199-208.
[http://dx.doi.org/10.1016/j.jmig.2017.08.009] [PMID: 28803811]
[17]
Haimovich S, López-Yarto M, Urresta Ávila J, Saavedra Tascón A, Hernández JL, Carreras Collado R. Office hysteroscopic laser enucleation of submucous fibroids without mass extraction: A case series study. BioMed Res Int 2015; 2015905204
[http://dx.doi.org/10.1155/2015/905204] [PMID: 26090457]
[18]
Friedman JA, Wong JMK, Chaudhari A, Tsai S, Milad MP. Hysteroscopic myomectomy: a comparison of techniques and review of current evidence in the management of abnormal uterine bleeding. Curr Opin Obstet Gynecol 2018; 30(4): 243-51.
[http://dx.doi.org/10.1097/GCO.0000000000000475] [PMID: 29939852]
[19]
Paulo AAS, Solheiro MHR, Paulo COS, Afreixo VMA. What proportion of women refers moderate to severe pain during office hysteroscopy with a mini-hysteroscope? A systematic review and meta-analysis. Arch Gynecol Obstet 2016; 293(1): 37-46.
[http://dx.doi.org/10.1007/s00404-015-3836-5] [PMID: 26253336]
[20]
Bradley LD, Widrich T. State-of-the-art flexible hysteroscopy for office gynecologic evaluation. J Am Assoc Gynecol Laparosc 1995; 2(3): 263-7.
[http://dx.doi.org/10.1016/S1074-3804(05)80106-9] [PMID: 9050568]
[21]
Bettocchi S, Bramante S, Bifulco G, et al. Challenging the cervix: strategies to overcome the anatomic impediments to hysteroscopy: analysis of 31,052 office hysteroscopies. Fertil Steril 2016; 105(5): e16-7.
[http://dx.doi.org/10.1016/j.fertnstert.2016.01.030] [PMID: 26873675]
[22]
Ahmad G, Attarbashi S, O’Flynn H, Watson AJ. Pain relief in office gynaecology: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2011; 155(1): 3-13.
[http://dx.doi.org/10.1016/j.ejogrb.2010.11.018] [PMID: 21255900]
[23]
Del Valle C, Solano JA, Rodríguez A, Alonso M. Pain management in outpatient hysteroscopy. Gynecol Minim Invas Ther 2016; 5(4): 141-7.
[http://dx.doi.org/10.1016/j.gmit.2016.08.001]
[24]
Asgari Z, Razavi M, Hosseini R, Nataj M, Rezaeinejad M, Sepidarkish M. Evaluation of paracervical block and IV sedation for pain management during hysteroscopic polypectomy: A randomized clinical trial. Pain Res Manag 2017; 2017: 5309408.
[http://dx.doi.org/10.1155/2017/5309408] [PMID: 28676733]
[25]
Hitchings S. Paracervical anaesthesia in outpatient hysteroscopy: a randomised double-blind placebo controlled trial. BJOG 2000; 107(1): 143-4.
[http://dx.doi.org/10.1111/j.1471-0528.2000.tb11597.x] [PMID: 10645879]
[26]
Giorda G, Scarabelli C, Franceschi S, Campagnutta E. Feasibility and pain control in outpatient hysteroscopy in postmenopausal women: a randomized trial. Acta Obstet Gynecol Scand 2000; 79(7): 593-7.
[http://dx.doi.org/10.1080/j.1600-0412.2000.079007593.x] [PMID: 10929961]
[27]
Readman E, Maher PJ. Pain relief and outpatient hysteroscopy: a literature review. J Am Assoc Gynecol Laparosc 2004; 11(3): 315-9.
[http://dx.doi.org/10.1016/S1074-3804(05)60042-4] [PMID: 15559340]
[28]
Carabias P, Celades-Filella M, Zapardiel I, Alsina-Maqueda A, Genover-Llimona E. Experience and results of office hysteroscopy at a primary hospital. J Obstet Gynaecol 2014; 34(1): 54-6.
[http://dx.doi.org/10.3109/01443615.2013.782277] [PMID: 24359051]
[29]
Munro MG, Brooks PG. Use of local anesthesia for office diagnostic and operative hysteroscopy. J Minim Invasive Gynecol 2010; 17(6): 709-18.
[http://dx.doi.org/10.1016/j.jmig.2010.07.009] [PMID: 20955982]
[30]
Gambadauro P, Navaratnarajah R, Carli V. Anxiety at outpatient hysteroscopy. Gynecol Surg 2015; 12(3): 189-96.
[http://dx.doi.org/10.1007/s10397-015-0895-3] [PMID: 26283891]
[31]
O’Flynn H, Murphy LL, Ahmad G, Watson AJ. Pain relief in outpatient hysteroscopy: a survey of current UK clinical practice. Eur J Obstet Gynecol Reprod Biol 2011; 154(1): 9-15.
[http://dx.doi.org/10.1016/j.ejogrb.2010.08.015] [PMID: 20926175]
[32]
Tam WH, Yuen PM. Use of diclofenac as an analgesic in outpatient hysteroscopy: a randomized, double-blind, placebo-controlled study. Fertil Steril 2001; 76(5): 1070-2.
[http://dx.doi.org/10.1016/S0015-0282(01)02832-1] [PMID: 11704141]
[33]
Zhuo Z, Yu H, Jiang X. A systematic review and meta-analysis of randomized controlled trials on the effectiveness of cervical ripening with misoprostol administration before hysteroscopy. Int J Gynaecol Obstet 2016; 132(3): 272-7.
[http://dx.doi.org/10.1016/j.ijgo.2015.07.039] [PMID: 26797202]
[34]
Tasma ML, Louwerse MD, Hehenkamp WJ, et al. Misoprostol for cervical priming prior to hysteroscopy in postmenopausal and premenopausal nulliparous women; a multicentre randomised placebo controlled trial. BJOG 2018; 125(1): 81-9.
[http://dx.doi.org/10.1111/1471-0528.14567] [PMID: 28109045]
[35]
Nada AM, Elzayat AR, Awad MH, et al. Cervical priming by vaginal or oral misoprostol before operative hysteroscopy: A double-blind, randomized controlled trial. J Minim Invasive Gynecol 2016; 23(7): 1107-12.
[http://dx.doi.org/10.1016/j.jmig.2016.08.002] [PMID: 27523921]
[36]
Kale A, Terzi H, Kale E. Sublingual misoprostol is better for cervical ripening prior to hysteroscopy in post-menopausal women. Clin Exp Obstet Gynecol 2014; 41(4): 402-4.
[PMID: 25134285]
[37]
Sordia-Hernández LH, Rosales-Tristan E, Vazquez-Mendez J, et al. Effectiveness of misoprostol for office hysteroscopy without anesthesia in infertile patients. Fertil Steril 2011; 95(2): 759-61.
[http://dx.doi.org/10.1016/j.fertnstert.2010.07.1066] [PMID: 20728083]
[38]
Connor M. New technologies and innovations in hysteroscopy. Best Pract Res Clin Obstet Gynaecol 2015; 29(7): 951-65.
[http://dx.doi.org/10.1016/j.bpobgyn.2015.03.012] [PMID: 25958129]
[39]
Chen CH, Lee WL, Wang IT, et al. Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix). Gynecol Minim Invas Ther 2013; 2(3): 89-92.
[http://dx.doi.org/10.1016/j.gmit.2013.05.005]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 1
Year: 2020
Page: [69 - 73]
Pages: 5
DOI: 10.2174/1573404815666191015194610
Price: $65

Article Metrics

PDF: 20
HTML: 3
EPUB: 1
PRC: 1